Loading news...
Neogen Corporation (NASDAQ: NEOG) on Wednesday initiated a voluntary nationwide recall of all unexpired lots of its Neogen Vet HYCOAT Hyaluronate Sodium Sterile Solution. The company identified microbial contamination in certain batches.
LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of 10 mL/50 mg product vials. Neogen received a number of reports of adverse events in horses following.
Neogen Corporation (NASDAQ: NEOG - Get Free Report) shares saw an uptick in trading volume on Friday. 4,702,857 shares changed hands during trading, a decline of 6% from the previous session's volume of 5,004,718 shares.The stock last traded at $9.9060 and had previously closed at $9.93. Analyst Ratings Changes A number of equities analysts have
Nisa Investment Advisors LLC lowered its position in shares of Neogen Corporation (NASDAQ: NEOG) by 79.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 25,884 shares of the company's stock after selling 102,152 shares during the period. Nisa Investment Advisors LLC's holdings
Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
NEOG's Q2 EPS and revenues top estimates, sending shares up 31.6% as the company raises its fiscal 2026 revenue and EBITDA outlook.
Shares of Neogen Corporation (NASDAQ: NEOG - Get Free Report) were down 5.5% during trading on Friday. The company traded as low as $8.44 and last traded at $9.1790. Approximately 1,803,973 shares traded hands during trading, a decline of 71% from the average daily volume of 6,287,906 shares. The stock had previously closed at $9.71.
The specialized healthcare company posted a beat-and-raise fiscal second quarter. Investors rushed into the stock, despite the fact that revenue and profitability were both down slightly year-over-year.
Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended November 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Neogen Corp. (NASDAQ: NEOG) stock rose after the company reported better-than-expected second-quarter financial results.
Neogen (NEOG) is experiencing a significant stock surge following its impressive Q2 report. Although the EPS beat was modest, the food safety and animal health
Neogen beat earnings estimates, raised its full-year revenue outlook, and has now posted back-to-back post-earnings stock spikes.
Neogen Corporation (NEOG) Q2 2026 Earnings Call Transcript
LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) announced today the results of the second quarter ended November 30, 2025. “I am exceptionally proud of the Neogen team as we have initiated the first phase of our strategic transformation with early work focused on stabilizing and strengthening our core business. While it is early in the process, and our industry is currently seeing macro headwinds, our team drove significant sequential improvement in core revenue growth and pr.
Neogen Corporation (NASDAQ: NEOG) will release earnings results for its first quarter before the opening bell on Thursday, Jan. 8, 2025.
LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) today announced the appointments of Joe Freels as Senior Vice President and Chief Commercial Officer, effective January 5, 2026, and Dr. Tammi Ranalli as Senior Vice President and General Manager, Global Food Safety, effective January 7, 2026. As Senior Vice President and General Manager for Neogen's Food Safety business unit, Dr. Ranalli will have full P&L responsibility for Neogen's global Food Safety portfolio and will de.
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its second-quarter earnings release before the opening of the market on January 8, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results. The conference call can be accessed by dialing: Toll-Free - North America: 1-800-549-8228 International: (+1) 646-564-2877 Conference ID: 82072 The live webcast can be acce.
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in two upcoming investor conferences. The Company will participate in the CJS Securities 26th Annual New Ideas for the New Year conference, held virtually on January 14, 2026. The Company will also participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, where Mike Nassif, Neogen's President and CEO, will present on January 14, 2026, at 5:15.
SAN DIEGO , Dec. 16, 2025 /PRNewswire/ -- Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in Neogen Corporation (NASDAQ: NEOG) shares. Investors who purchased shares of Neogen Corporation prior to January 2023 and continue to hold any of those NASDAQ: NEOG shares also have certain options and contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Neogen leans on new product launches and 3M Food Safety integration to offset solvency strains and macro pressures.